Sign in Subscribe
Coronary heart disease

Central Sleep Apnea: New Insights and Treatment Options

Strategic Insights

— 1 min read

According to a recent study, central sleep apnea (CSA) is a serious condition that can lead to numerous long-term consequences, including arrhythmias, hypertension, congestive heart failure, stroke, and type 2 diabetes, among others. Researchers at Parkview Regional Medical Center have found significant improvement in patients with CSA using the remede System, a phrenic nerve stimulator.

Key Takeaways:

  • CSA is a secondary condition caused by inadequate ventilation during sleep, resulting in repeated hypoxic episodes and long-term consequences.
  • The remede System, a phrenic nerve stimulator, is indicated for treatment of moderate-to-severe CSA in adults.
  • A 60-year-old male patient with obesity, essential hypertension, seizure, and stroke showed significant improvement in AHI and resolution of CSA after remede System implantation.
  • The patient's verbal fluency, mathematical skills, and cognition also improved with the use of remede System.
  • The study concluded that phrenic nerve stimulation therapy can be an effective treatment for CSA.
  • The remede System has been peer-reviewed and has shown significant benefits in reducing AHI and CSA indices in patients.

Statistics:

  • 63.4 average apnea-hypopnea index (AHI) per hour before treatment
  • 51.8 central apnea index per hour before treatment
  • 73% lowest oxygen saturation before treatment
  • 6.9 minutes of nocturnal hypoxemia below 88% oxygen saturation before treatment
  • 11.4 AHI per hour after treatment
  • 0.0 central apnea index per hour after treatment
  • 84% lowest oxygen saturation after treatment
  • 3.2 minutes of nocturnal hypoxemia below 88% oxygen saturation after treatment

Sources:

  • Researchers from Parkview Regional Medical Center

Parkview Regional Medical Center

Fort Wayne, United States

Ram Verma, Sleep Medicine

Parkview Regional Medical Center

Fort Wayne, United States

NewsRx LLC. (2025, November 3). Researchers from Parkview Regional Medical Center Describe Findings in Central Sleep Apnea (An Interesting Outcome of Central Sleep Apnea With Phrenic Nerve Stimulation Therapy). Obesity & Diabetes Week, 148.

Read more